A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis
- PMID: 12203177
- DOI: 10.1086/342299
A randomized, double-blind, placebo-controlled trial of acetazolamide for the treatment of elevated intracranial pressure in cryptococcal meningitis
Abstract
We conducted a trial of oral acetazolamide for the treatment of cryptococcal meningitis in 22 Thai adults with headache and an opening cerebrospinal fluid pressure of >/=200 mm H(2)0. The trial was terminated prematurely because patients who received acetazolamide developed significantly lower venous bicarbonate levels and higher chloride levels and had more-frequent serious adverse events than did subjects who received placebo.
Comment in
-
Acetazolamide therapy and intracranial pressure.Clin Infect Dis. 2003 Feb 15;36(4):538. doi: 10.1086/367646. Clin Infect Dis. 2003. PMID: 12567320 No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
